HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Clinical trial NCT03758456 · COMPLETED
Trial details
- NCT number
- NCT03758456
- Sponsor
- HAL Allergy
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2019-05-17
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.